- Gastroenterology Conference 2019, all presentationsOriginal Date: October 19-20, 2019This discounted package includes all of the individual presentations from the conference, which are listed below.12.5 CEUs (including 1.5 pharmacy, 1.0 ethics, and 10.0 general) approved by OBNM
- Acute Cholecystitis: How To Save a Gallbladder From Surgical RemovalPresenter: Mona Morstein, ND, DHANPOriginal Date: October 19, 2019Gallstones are very common among patients and cause biliary colic and/or cholecystitis, leading to 300,000 cholecystectomies a year. Naturopathic medicine is a valuable tool in healing gallstone problems and even reducing/eradicating gallstones. Dr. Morstein presents comprehensive information on gallstones, the signs and symptoms of them, and gives specific clinical details on how to treat them. She presents two successful cases with U/S verification of her treatments.Ursodiol is briefly mentioned1.0 general CEUs approved by OBNM
- The Ethics of Prescribing a Gluten Free DietPresenter: Lisa Shaver, ND, LAcOriginal Date: October 19, 2019The gluten-free diet is a frequent staple in a practitioner’s list of modalities to use for a myriad of conditions. “Try a gluten-free diet” or “go gluten-free” has become a common phrase heard even between friends and neighbors, nutritionists and bloggers. However, a gluten-free diet (GFD) is a medical prescription for celiac disease. When prescribing a GFD prior to thoroughly testing for celiac disease, a practitioner is unwittingly denying that patient a chance at revealing the root cause of symptoms and a life-long/permanent systems-damaging inflammatory autoimmune process with grave associated repercussions. We wouldn’t ask a non-type 1 diabetic to “try insulin” – it’s inappropriate. As conscientious practitioners, the medical community needs to be diagnosing celiac disease appropriately, or thoroughly ruling it out, prior to prescribing a GFD.Dr. Shaver presents the top reasons why prescribing a GFD is unethical in the absence of first performing thorough testing for celiac disease, from high risks of developing other unidentified autoimmune diseases to repercussions amid an entire family tree, to increase risks for cancers in celiacs who continue undiagnosed.1.0 ethics CEUs approved by OBNM
- Microscopic ColitisPresenter: Steven Sandberg-Lewis, ND, DHANPOriginal Date: October 19, 2019Lymphocytic colitis (LC) and collagenous colitis (CC) are two causes of chronic non-bloody diarrhea, and are coupled under the diagnosis of microscopic colitis (MC). These are inflammatory diseases of the colon which have no gross changes and are identified by histology alone. Dr. Sandberg-Lewis has treated a significant number of cases of MC. In this presentation he defines these conditions, explains their known etiology, risk factors and pathophysiology and focuses in more detail on the most effective standard and Naturopathic treatment and management strategies. Pharmacology is included in this discussion (drug causes of MC, dosages and tapering strategies for prescription medicines and some off label approaches.)Indeterminate colitis is also discussed – that condition that falls between Crohn’s colitis and ulcerative colitis. Even with the eclectic approach of NDs, knowing the definitive diagnosis for inflammatory bowel disease holds importance and allows you to focus your treatment toward more proven options rather than guessing. What do you do when there is no definitive diagnosis? Sandberg-Lewis attempts to demystify this – discussing his approach in these situations.1.5 CEUs (0.5 pharmacy and 1.0 general) approved by OBNM
- Gastroparesis: An Integrative ApproachPresenter: Lela Altman, ND, LAc, EAMPOriginal Date: October 19, 2019This presentation goes through the underlying causes, prognosis of and complications associated with gastroparesis. Management options discussed include herbal, pharmaceutical, dietary, surgical, manual, mind-body and acupuncture treatments. After this lecture, the learner should come away with a greater understanding of the management of gastroparesis in a clinical setting.Pharmaceuticals discussed include erythromycin, azithromycin, domperidone, prucalopride and metoclopramide.1.0 CEUs (0.5 pharmacy and 0.5 general) approved by OBNM
- Hormones and Their Effect on DigestionPresenter: Debbie Rice, NDOriginal Date: October 19, 2019Overall objectives and goals for this presentation are to discuss sex hormones and adrenal hormones, production, and the overall effect of these hormones on digestion and Gastrointestinal function.Estrogen has been shown to have significant effects on the gastrointestinal microbiome, including estrobolome, which is necessary for estrogen metabolism in the gut. Estrobolome influences beta-glucaronidase and its influence on gut health, as well as estrogen’s effect on inflammation, mucosal barriers, and immune function. Gut microbiome imbalances and estrogen levels are a highly complex and intertwined system affecting other components of health including immune function, cardiovascular risk, obesity, and other metabolic pathologies. Progesterone has been found to highly influence the time for bowel emptying and movement through the bowels, especially related to the luteal phase of the menstrual cycle.Adrenal hormones such as cortisol and DHEA are influenced by gut microbiome imbalance and gut inflammation. Cortisol can be anti-inflammatory with regard to IBS pathologies in certain instances. Too much cortisol can dampen appropriate enzyme release and appropriate anti-inflammatory response. DHEA levels are an integral component of immune and anti-inflammatory support of overall digestion and GI function.0.75 general CEUs approved by OBNM
- Unveiling the Intersection of Gut, Brain, and HormonesPresenter: Corina Dunlap, ND, MSOriginal Date: October 19, 2019There is an important link between gastrointestinal function, brain, hormones, and health. Why do some women feel bloated or have stool changes with fluctuations in their menstrual cycle? What about PMS, including symptoms such as anxiety and depression, all coinciding with gastrointestinal health? In the past decade, there have been huge advancements in the research on this topic. Now we see a relationship between the gut microbiome, our mood, and our memory. We see a higher percentage of people with IBS or other bowel problems suffering from depression and anxiety. We see gut inflammation impacting a whole range of issues from pain, sleep, and libido to mental health. We see probiotic therapy used in place of some anti-depressants with equal success. We've found evidence of direct communication from gut to brain, a type of neural superhighway.This presentation attempts to connect some of these dots in order to shed light on how this intersection may impact our approach to case management.1.25 general CEUs approved by OBNM
- IBD BootcampPresenter: Ilana Gurevich, ND, LAcOriginal Date: October 20, 2019This is a 60 minute power course orienting everyone into the world of inflammatory bowel disease. We discuss foundational presentation of IBD, pharmaceutical management of IBD and naturopathic treatment options for IBD.Pharmaceuticals discussed:
- 5-ASA drugs like sulfasalazine, mesalamine drugs, prednisone, budesonide, biologic agents like infliximab, ada Infliximab, Adalimumab, Certolizumab pegol, Natalizumab, Vedolizumab and Ustekinumab and immunosupressants like Azathioprine, Mercaptopurine and Methotrexate
1.0 CEUs (0.5 pharmacy and 0.5 general) approved by OBNM - Outlet Dysfunction Constipation: Diagnosis & Treatment ConsiderationsPresenter: Sabrina Kimball, ND, LAc, EAMPOriginal Date: October 20, 2019Outlet dysfunction constipation is commonly overlooked cause of chronic constipation. This group of conditions is often a consequence of poor coordination of colonic, abdominal, pelvic and rectal musculature resulting in ineffective or incomplete expulsion of stool during defecation. This can be caused by weak colonic contractions, rectal hyposensitivity, rectal outlet obstruction, poor lower abdominal muscle recruitment, increased ano-rectal muscle tone or anismus. It is estimated that about 50% of those with outlet dysfunction constipation also suffer from slow transit constipation. Outlet dysfunction constipation should be evaluated first in-office with a detailed history and physical examination. Further evaluation by a pelvic floor physical therapist or GI motility specialist is often warranted. Dr. Kimball discusses when to refer and common treatment approaches performed by specialists.Treatment of outlet dysfunction constipation requires a coordinated and personalized approach to treatment to achieve resolution. As part of this presentation, Dr. Kimball reviews the application of behavioral modifications, dietary modifications, physical therapy, nutritional supplements, pharmaceuticals and biofeedback therapy to address outlet dysfunction constipation disorders. Also discussed is the use of osmotic laxatives, stool softeners, enemas, colonic secretogogues: linclotide and lubiprostone, muscle relaxants: tizanidine and cyclobenzaprine, and botulinum toxin injection.1.0 general CEUs approved by OBNM
- Is Your Tail Talking?: Clinical Approaches to Common Anorectal DisordersPresenter: Crane Holmes, NDOriginal Date: October 20, 2019Gastrointestinal health spans from the mouth to the anus, but rarely the tail end is talked about. During this lecture, we discuss how common GI conditions such as constipation, diarrhea or bloody stools may cause and be causing changes in anorectal health. Intimidated to take a look? We review the rectal examination, as well as prostate exam, to determine if a patient’s anorectal health may be the cause of their IBS. We will also offer both conventional and holistic approaches to help patients achieve immediate relief from their poor anorectal health as well as prevent reoccurrence of disease.1.0 general CEUs approved by OBNM
- Individualizing Botanical Medicines for Patients with IBDPresenter: Mark Davis, NDOriginal Date: October 20, 2019Over the past several decades, we have gained immense insight into the world of the human microbiome. The observations made using techniques like Fecal Microbiota Transplant and microbial sequencing are contributing to a new paradigm of what it means to be human. We now know we are not alone in our own bodies. We are a compilation of trillions of microbes and human cells working together as an ecosystem with the bulk of this ecosystem residing in our colon. This ecosystem and the repercussions of its health are now being investigated outside the local GI system. The colonic microbiome is communicating with our brain through neuroimmune, neuroendocrine, and direct sensory input. The bi-directional role this gut-brain axis has on health expands our understanding of what GI and mental health really means.1.0 general CEUs approved by OBNM
- The Gut-Brain Axis: Emerging Science of the Microbiome’s RolePresenter: Andrea Mcbeth, ND, and Heather Zwickey, PhDOriginal Date: October 20, 2019Over the past several decades, we have gained immense insight into the world of the human microbiome. The observations made using techniques like Fecal Microbiota Transplant and microbial sequencing are contributing to a new paradigm of what it means to be human. We now know we are not alone in our own bodies. We are a compilation of trillions of microbes and human cells working together as an ecosystem with the bulk of this ecosystem residing in our colon. This ecosystem and the repercussions of its health are now being investigated outside the local GI system. The colonic microbiome is communicating with our brain through neuroimmune, neuroendocrine, and direct sensory input. The bi-directional role this gut-brain axis has on health expands our understanding of what GI and mental health really means.1.5 general CEUs approved by OBNM
